3-(ethoxycarbonyl)-1-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

GC capillary column ROTI®Cap-5, 60 m, 0.25 mm, 0.10 µm, 1 Piece(s)

4-Bromo-2-methyl-1H-imidazole, 95.0%, 1g

5-(Bromomethyl)-2-methylpyrimidin-4-amine hydrobromide, 95.0%, 250mg

[1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)ethyl]amine dihydrochloride, 95.0%, 5g

tert-Butyl (2-oxo-2-(prop-2-yn-1-ylamino)ethyl)carbamate, 95%, 100mg

Hexanediimidic acid, 1,6-dimethyl ester, hydrochloride (1:2), 5g

3-Cyano-4-propoxybenzoic acid, 98%, 100mg

[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid, 97%, 5mg

5-Chlorobenzofuran-2-carboxylic acid, 97.0%, 1g

4'-Chloro-2'-fluoroacetanilide>98.0%(GC)25g

(S)-tert-Butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate, 97.0%, 250mg

2,3-Dimethyl-1,3-benzothiazol-3-ium Iodide>98.0%(HPLC)(T)5g